The purpose of this study is to investigate the clinical outcomes and glucose control metrics of critically ill patients with previously undiagnosed diabetes compared to those with known diabetes at the time of admission to the intensive care unit (ICU).
This case control study compares previously undiagnosed diabetic patients (defined as HbA1c \> 6.5% and no history of diabetes), to those with known diabetes, using 1:1 matching. Patients met inclusion criteria by having HbA1c available on ICU admission and at least four blood glucose tests during their ICU stay. Primary outcomes included ICU length of stay and inpatient mortality. Secondary outcomes included glucose metrics: mean blood glucose, coefficient of variation and percentage of patients who developed hypoglycemia.
Study Type
OBSERVATIONAL
Enrollment
1,777
HbA1c \> 6.5%
Stamford Health
Stamford, Connecticut, United States
Inpatient mortality
Estimates the risk of short-term mortality based on data from the initial 24 hours of intensive care unit (ICU) admission. Acute Physiology and Chronic Health Evaluation (APACHE) IV
Time frame: 2011-2019
Length of hospital Stay
Total days spent admitted to the hospital
Time frame: 2011-2019
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.